Navigation Links
Star panel re-evaluates Sarbanes-Oxley one year in at SEC headquarters

Washington, D.C. A full house packed the Securities and Exchange Commission headquarters on Wednesday for a public forum to discuss the most onerous section of The Sarbanes-Oxley Act of 2002 (or Sarbanes-Oxley), Section 404.

The event was a roundtable of public companies, auditors, investors, and members of the legal community to discuss the pros and......

Full article >>> nym> that needs to be addressed.

Auditors are very conservative these days in light of their heightened liability environment and the unknowns regarding PCAOB's relatively new inspection process. Companies are responding to the most significant regulatory changes since the Securities Exchange Act of 1934 with little guidance, and the regulators themselves are working fr......

Full article >>> panies may be under-emphasizing. Some may be spending too much time on traditional accounting controls at the expense of entity-wide controls such as control environment (which includes tone-at-the-top), risk awareness, monitoring, and information and communication. If management is not exhibiting proper ethical values and actions consistent with sound controls, this weakens the entire foundation ......

Full article >>> l@candelasolutions.com">rkral@candelasolutions.com or 608-204-0122, ext. 23.
......

Full article >>>
'"/>

Source:wistechnology.com By Ron Kral 04/13/05


Related biology technology :

1. Flat panel displays
2. National stem-cell panel, including UW profs, urges close watch on research
3. The role of IT in Sarbanes-Oxley Section 404
4. With Sarbanes-Oxley, compliance takes center stage for CIOs
5. Rayovacs IT team discusses network security, Sarbanes-Oxley and ROI myths
6. Observations from the Sarbanes-Oxley trenches
7. Technology Implications of Sarbanes-Oxley
8. Sarbanes-Oxley for the Rest of Us
9. Sarbanes-Oxley Act: The Next Y2K For IT Budgets?
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/22/2017)... 22, 2017 Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), today ... (RGC), U.K. Biobank and GSK to generate genetic sequence data ... The initiative will enable researchers to gain valuable insights to ... wide range of serious and life threatening diseases. ... Genetic evidence ...
(Date:3/22/2017)... March 22, 2017  UBM and the Massachusetts ... their extended partnership and the third annual Massachusetts Medtech ... the 21 st Annual MassMEDIC Conference held ... May 3-4, 2017. MassMEDIC will ... (ADVAMED) President and CEO, Scott Whitaker , ...
(Date:3/22/2017)... Mass. , March 22, 2017   iSpecimen ... today announced that Doctors Pathology Service (DPS), ... region of the United States , ... Delaware Health Information Network (DHIN) to make ... The novel program, announced in 2015 ...
(Date:3/22/2017)... - FACIT announced a seed stage investment in ... created by FACIT focused on developing a portfolio ... non-dilutive capital, achieves a targeted $3.0M financing for ... to accelerate the nomination of a candidate drug ... a strategic partnership for clinical trials in patients ...
Breaking Biology Technology:
(Date:2/27/2017)... Feb. 27, 2017   Strategic Cyber Ventures , ... has led a $3.5 million investment in  Polarity , ... Cyber Ventures is DC based and is led by ... Thomas . Ron Gula , also a longtime ... participated in this series A round of funding. This ...
(Date:2/21/2017)... LONDON , February 21, 2017 ... um 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr ... es einige Hindernisse zu überwinden gilt, um diese Prognose ... ... unter anderem die Mobilisierung der finanziellen Mittel für die ...
(Date:2/10/2017)... 10, 2017 Research and Markets ... "Personalized Medicine - Scientific and Commercial Aspects" to their ... ... is integrated with therapy for selection of treatment as well ... and prevention of disease in modern medicine. Biochip/microarray technologies and ...
Breaking Biology News(10 mins):